Source link : https://www.newshealth.biz/health-news/new-car-t-drug-induces-durable-remissions-in-all-published-data-show/
Use of the anti-CD19 CAR T-cell therapy obecabtagene autoleucel (obe-cel; Aucatzyl) resulted in durable remissions among patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), according to results from the phase Ib/II FELIX trial. In a cohort of 94 patients with morphologic disease, overall remission occurred in 77% of those who received at least […]
Author : News Health
Publish date : 2024-11-27 22:00:00
Copyright for syndicated content belongs to the linked Source.